Hikma Pharmaceuticals PLC (HKMPY)
50.90
-0.65
(-1.26%)
USD |
OTCM |
May 17, 16:00
Hikma Pharmaceuticals Price: 50.90 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 50.90 | 50.90 | 50.90 | 50.90 | 1077.00 |
| May 16, 2024 | 51.55 | 51.55 | 51.55 | 51.55 | 0.000 |
| May 15, 2024 | 51.55 | 51.55 | 51.55 | 51.55 | 349.00 |
| May 14, 2024 | 50.08 | 50.08 | 50.08 | 50.08 | 0.000 |
| May 13, 2024 | 50.08 | 50.08 | 50.08 | 50.08 | 0.000 |
| May 10, 2024 | 50.55 | 50.55 | 49.97 | 50.08 | 10184.00 |
| May 09, 2024 | 49.00 | 49.00 | 49.00 | 49.00 | 0.000 |
| May 08, 2024 | 49.00 | 49.00 | 49.00 | 49.00 | 0.000 |
| May 07, 2024 | 49.00 | 49.00 | 49.00 | 49.00 | 0.000 |
| May 06, 2024 | 49.00 | 49.00 | 49.00 | 49.00 | 4947.00 |
| May 03, 2024 | 49.02 | 49.02 | 49.02 | 49.02 | 0.000 |
| May 02, 2024 | 49.02 | 49.02 | 49.02 | 49.02 | 363.00 |
| May 01, 2024 | 46.16 | 46.16 | 46.16 | 46.16 | 1111.00 |
| Apr 30, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 29, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 26, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 25, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 24, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 23, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 22, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 19, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 18, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 17, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 16, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 0.000 |
| Apr 15, 2024 | 46.50 | 46.50 | 46.50 | 46.50 | 247.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
26.02
Minimum
Oct 21 2022
75.81
Maximum
Aug 02 2021
52.47
Average
51.36
Median
Nov 06 2019
Price Benchmarks
| Adaptimmune Therapeutics PLC | 1.10 |
| Biodexa Pharmaceuticals Plc | 1.18 |
| Verona Pharma PLC | 13.00 |
| NuCana PLC | 3.61 |
| Autolus Therapeutics PLC | 4.40 |
Price Related Metrics
| PE Ratio | 29.94 |
| PS Ratio | 1.968 |
| Price to Book Value | 2.569 |
| Price to Free Cash Flow | 10.62 |
| Earnings Yield | 3.34% |
| Market Cap | 5.647B |
| Operating PE Ratio | 9.369 |
| Normalized PE Ratio | 15.66 |